{
  "meta": {
    "id": "test9",
    "title": "Drugs in Gynae",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "Which of the following drugs is commonly used for hormone replacement therapy in post menopausal women to alleviate menopausal symptoms?",
      "options": [
        {
          "label": "A",
          "text": "SSRIs",
          "correct": false
        },
        {
          "label": "B",
          "text": "Bisphosphonates",
          "correct": false
        },
        {
          "label": "C",
          "text": "GnRH agonists",
          "correct": false
        },
        {
          "label": "D",
          "text": "Estrogen/ progestin combination therapy",
          "correct": true
        }
      ],
      "correct_answer": "D. Estrogen/ progestin combination therapy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Estrogen/ progestin combination therapy</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Estrogen/ progestin therapy is commonly used as HRT to alleviate post-menopausal symptoms Estrogen primarily alleviates symptoms and progesterone is added to protect the lining of the uterus and reduces the risk of endometrial hyperplasia and cancer</li><li>\u2022 Estrogen/ progestin therapy is commonly used as HRT to alleviate post-menopausal symptoms</li><li>\u2022 Estrogen primarily alleviates symptoms and progesterone is added to protect the lining of the uterus and reduces the risk of endometrial hyperplasia and cancer</li><li>\u2022 Other Options</li><li>\u2022 Other Options</li><li>\u2022 Option A: SSRIs are not standard therapy for post-menopausal symptoms but may be prescribed in specific cases to address mood relate menopausal symptoms Option B: Bisphosphonates are medications used to prevent and treat osteoporosis Option C: GnRH agonists are not used for HRT</li><li>\u2022 Option A: SSRIs are not standard therapy for post-menopausal symptoms but may be prescribed in specific cases to address mood relate menopausal symptoms</li><li>\u2022 Option B: Bisphosphonates are medications used to prevent and treat osteoporosis</li><li>\u2022 Option C: GnRH agonists are not used for HRT</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Estrogen/ progestin therapy is commonly used as HRT to alleviate post-menopausal symptoms Estrogen primarily alleviates symptoms and progesterone is added to protect the lining of the uterus and reduces the risk of endometrial hyperplasia and cancer So in women who have a uterus, in HRT: Estrogen + Progesterone both are given In women without a uterus (post hysterectomy): in HRT, only estrogen is suffiecient</li><li>\u27a4 Estrogen/ progestin therapy is commonly used as HRT to alleviate post-menopausal symptoms</li><li>\u27a4 Estrogen primarily alleviates symptoms and progesterone is added to protect the lining of the uterus and reduces the risk of endometrial hyperplasia and cancer So in women who have a uterus, in HRT: Estrogen + Progesterone both are given In women without a uterus (post hysterectomy): in HRT, only estrogen is suffiecient</li><li>\u27a4 So in women who have a uterus, in HRT: Estrogen + Progesterone both are given In women without a uterus (post hysterectomy): in HRT, only estrogen is suffiecient</li><li>\u27a4 So in women who have a uterus, in HRT: Estrogen + Progesterone both are given</li><li>\u27a4 In women without a uterus (post hysterectomy): in HRT, only estrogen is suffiecient</li><li>\u27a4 Ref: Page no 1420, Speroff\u2019s Gynecology, 9 th edition</li><li>\u27a4 Ref: Page no 1420, Speroff\u2019s Gynecology, 9 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6003d82c",
      "audio": ""
    },
    {
      "text": "A 42-year woman presents with heavy menstrual bleeding and dysmenorrhoea. Pelvic ultrasound reveals an intramural fibroid measuring 3 cm. The woman desires medical management rather than surgical intervention. Which of the following would be the most appropriate 1 st line drug in this woman?",
      "options": [
        {
          "label": "A",
          "text": "Antifibrinolytic with NSAID",
          "correct": true
        },
        {
          "label": "B",
          "text": "Combined estrogen progesterone",
          "correct": false
        },
        {
          "label": "C",
          "text": "GnRH antagonist",
          "correct": false
        },
        {
          "label": "D",
          "text": "Ulipristal acetate",
          "correct": false
        }
      ],
      "correct_answer": "A. Antifibrinolytic with NSAID",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Antifibrinolytic with NSAID</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Fibroids can be managed medically or surgically or by newer techniques</li><li>\u27a4 Fibroids can be managed medically or surgically or by newer techniques</li><li>\u27a4 Drugs for Medical Management</li><li>\u27a4 Drugs for Medical Management</li><li>\u27a4 NSAIDs Anti-fibrinolytics (Tranexamic acid)</li><li>\u27a4 NSAIDs</li><li>\u27a4 NSAIDs</li><li>\u27a4 Anti-fibrinolytics (Tranexamic acid)</li><li>\u27a4 Anti-fibrinolytics (Tranexamic acid)</li><li>\u27a4 A combination of Antibrinolytic and NSAIDs are usually tried as a 1 st line management in women with HMB and dysmenorrhoea</li><li>\u27a4 3. Combined Estrogen and Progesterones: these are effective in reducing bleeding and pain during periods in women with fibroids.</li><li>\u27a4 3. Combined Estrogen and Progesterones:</li><li>\u27a4 4. SPRMs: Mifepristone (RU 486) and Ulipristal acetate</li><li>\u27a4 4. SPRMs:</li><li>\u27a4 Is very effective to reduce fibroid size and also menorrhagia. It reduces the size of the fibroid significantly. Long-term therapy with mifepristone is avoided as it causes endometrial hyperplasia. Ulipristal acetate is also used for 3 months. IT is associated with liver toxicity</li><li>\u27a4 Is very effective to reduce fibroid size and also menorrhagia.</li><li>\u27a4 It reduces the size of the fibroid significantly.</li><li>\u27a4 Long-term therapy with mifepristone is avoided as it causes endometrial hyperplasia.</li><li>\u27a4 Ulipristal acetate is also used for 3 months. IT is associated with liver toxicity</li><li>\u27a4 5. Danazol:</li><li>\u27a4 5. Danazol:</li><li>\u27a4 Can reduce the volume of a fibroid slightly. Because of androgenic side effects, danazol is used only for a period of 3\u20136 months. Not commonly used now</li><li>\u27a4 Can reduce the volume of a fibroid slightly.</li><li>\u27a4 Because of androgenic side effects, danazol is used only for a period of 3\u20136 months.</li><li>\u27a4 Not commonly used now</li><li>\u27a4 6. GnRH agonists:</li><li>\u27a4 6. GnRH agonists:</li><li>\u27a4 Drugs commonly used are goserelin, leprolin, buserelin or nafarelin Mechanism of action is sustained pituitary down regulation and suppression of ovarian function. Optimal duration of therapy is 3 months. Addback therapy may be needed to combat hypoestrogenic symptoms Reduces size of fibroid by upto 50% at 3 months</li><li>\u27a4 Drugs commonly used are goserelin, leprolin, buserelin or nafarelin</li><li>\u27a4 Mechanism of action is sustained pituitary down regulation and suppression of ovarian function.</li><li>\u27a4 Optimal duration of therapy is 3 months.</li><li>\u27a4 Addback therapy may be needed to combat hypoestrogenic symptoms</li><li>\u27a4 Reduces size of fibroid by upto 50% at 3 months</li><li>\u27a4 7. GnRH antagonists</li><li>\u27a4 7. GnRH antagonists</li><li>\u27a4 Cetrorelix or ganirelix causes immediate suppression of pituitary and the ovaries. They do not have the initial stimulatory effect. Benefits are same as that of agonists Onset of amenorrhea is rapid.</li><li>\u27a4 Cetrorelix or ganirelix causes immediate suppression of pituitary and the ovaries.</li><li>\u27a4 They do not have the initial stimulatory effect. Benefits are same as that of agonists</li><li>\u27a4 Onset of amenorrhea is rapid.</li><li>\u27a4 8. Levonorgestrel-releasing Intrauterine System (LNG-IUS):</li><li>\u27a4 8. Levonorgestrel-releasing Intrauterine System (LNG-IUS):</li><li>\u27a4 Reduces blood loss and uterine size. However, this is not recommended when the uterine size is >12 weeks or if the cavity is distorted.</li><li>\u27a4 Reduces blood loss and uterine size.</li><li>\u27a4 However, this is not recommended when the uterine size is >12 weeks or if the cavity is distorted.</li><li>\u27a4 Ref: page 209, Williams Gynecology 3 rd edition</li><li>\u27a4 Ref: page 209, Williams Gynecology 3 rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "dbaa3e1a",
      "audio": ""
    },
    {
      "text": "Which of the following progesterone medications is commonly used in HRT in menopausal women to protect the uterus from the potential risks of estrogen therapy?",
      "options": [
        {
          "label": "A",
          "text": "Medroxyprogesterone acetate",
          "correct": true
        },
        {
          "label": "B",
          "text": "Micronized progesterone",
          "correct": false
        },
        {
          "label": "C",
          "text": "\u2018Norethindrone",
          "correct": false
        },
        {
          "label": "D",
          "text": "Levonorgestrel",
          "correct": false
        }
      ],
      "correct_answer": "A. Medroxyprogesterone acetate",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Medroxyprogesterone acetate</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Hormone replacement therapy (HRT) consists of Estrogen and Progesterone Medroxyprogesterone acetate is the most commonly used progesterone component for menopausal women, and this is given to protect the uterus from hyperplasia/ malignancy Conjugated equine estrogen is the most common estrogen used in HRT</li><li>\u2022 Hormone replacement therapy (HRT) consists of Estrogen and Progesterone</li><li>\u2022 Medroxyprogesterone acetate is the most commonly used progesterone component for menopausal women, and this is given to protect the uterus from hyperplasia/ malignancy</li><li>\u2022 Conjugated equine estrogen is the most common estrogen used in HRT</li><li>\u2022 Other Options</li><li>\u2022 Other Options</li><li>\u2022 Option B: Micronized progesterone is commonly used in pregnancy in women at risk of preterm labor Option C: Norethindrone and Option D : levonorgestrel are usually part of combined contraceptive pills. LNG is also used as an intra uterine device (Mirena)</li><li>\u2022 Option B: Micronized progesterone is commonly used in pregnancy in women at risk of preterm labor</li><li>\u2022 Option B:</li><li>\u2022 Option C: Norethindrone and Option D : levonorgestrel are usually part of combined contraceptive pills. LNG is also used as an intra uterine device (Mirena)</li><li>\u2022 Option C:</li><li>\u2022 Option D</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Hormone replacement therapy (HRT) consists of Estrogen and Progesterone Medroxyprogesterone acetate is the most commonly used progesterone component for menopausal women, and this is given to protect the uterus from hyperplasia/ malignancy</li><li>\u27a4 Hormone replacement therapy (HRT) consists of Estrogen and Progesterone</li><li>\u27a4 Medroxyprogesterone acetate is the most commonly used progesterone component for menopausal women, and this is given to protect the uterus from hyperplasia/ malignancy</li><li>\u27a4 Ref:  Page no 1420, Speroff\u2019s Gynecology, 9 th edition</li><li>\u27a4 Ref:  Page no 1420, Speroff\u2019s Gynecology, 9 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "626d70e3",
      "audio": ""
    },
    {
      "text": "A 28-year-old woman presents with infertility and is diagnosed with anovulatory cycles. Which of the following medications can be used for ovulation induction in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Clomiphene citrate",
          "correct": false
        },
        {
          "label": "B",
          "text": "Letrozole",
          "correct": false
        },
        {
          "label": "C",
          "text": "Both clomiphene citrate and letrozole",
          "correct": true
        },
        {
          "label": "D",
          "text": "Gonadotropin-releasing hormone (GnRH) agonists",
          "correct": false
        }
      ],
      "correct_answer": "C. Both clomiphene citrate and letrozole",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Both clomiphene citrate and letrozole</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 A. Clomiphene citrate is a selective estrogen receptor modulator (SERM) that blocks the negative feedback of estrogen on the hypothalamus, leading to increased production and release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH). This promotes follicular growth and ovulation.</li><li>\u2022 B. Letrozole is an aromatase inhibitor that reduces the conversion of androgens to estrogen, leading to decreased estrogen levels and increased FSH production. It has been found to be equally effective or even superior to clomiphene citrate in some cases, particularly in women with polycystic ovary syndrome (PCOS).</li><li>\u2022 Hence Option C (Option A + B) is the answer</li><li>\u2022 Hence Option C (Option A + B) is the answer</li><li>\u2022 Other Options</li><li>\u2022 Option D. Gonadotropin-releasing hormone (GnRH) agonists are not typically used for primary ovulation induction. They are more commonly used to suppress ovulation temporarily in certain fertility treatment protocols or for medical management of specific conditions, such as endometriosis.</li><li>\u2022 Option D.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Both letrozole and clomiphene citrate are commonly used ovulation induction agents. Gonadotropins (FSH and HMG) are 2nd line drugs. The choice between clomiphene citrate and letrozole may depend on various factors, including the patient's individual characteristics, response to prior treatments, and underlying conditions such as PCOS. In some cases, a healthcare provider may choose to use one medication over the other based on individual patient factors. Rememebr: If PCOS is mentioned, Letrozole would be the preferred agent for ovulation induction, even though clomiohene citrate can also be used</li><li>\u27a4 Both letrozole and clomiphene citrate are commonly used ovulation induction agents. Gonadotropins (FSH and HMG) are 2nd line drugs.</li><li>\u27a4 Both letrozole and clomiphene citrate are commonly used ovulation induction agents. Gonadotropins (FSH and HMG) are 2nd line drugs.</li><li>\u27a4 The choice between clomiphene citrate and letrozole may depend on various factors, including the patient's individual characteristics, response to prior treatments, and underlying conditions such as PCOS. In some cases, a healthcare provider may choose to use one medication over the other based on individual patient factors.</li><li>\u27a4 Rememebr: If PCOS is mentioned, Letrozole would be the preferred agent for ovulation induction, even though clomiohene citrate can also be used</li><li>\u27a4 Rememebr:</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ceaa7aa1",
      "audio": ""
    },
    {
      "text": "Match the following drugs used in gynecology with their corresponding indication of use:",
      "options": [
        {
          "label": "A",
          "text": "A-2 B-1 C-4 D-3",
          "correct": false
        },
        {
          "label": "B",
          "text": "A-1 B-2 C-4 D-3",
          "correct": true
        },
        {
          "label": "C",
          "text": "A-3 B-1 C-2 D-4",
          "correct": false
        },
        {
          "label": "D",
          "text": "A-4 B-2 C-1 D-3",
          "correct": false
        }
      ],
      "correct_answer": "B. A-1 B-2 C-4 D-3",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/16/1.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. A-1 B-2 C-4 D-3</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Dienogest is a progesterone; used in management of endometriosis (either alone or in combination with estrogen) Letrozole is commonly used for ovulation induction, but recent WHO guidelines have recommended its use in 1 st trimester MTP along with misoprostol Ulipristal acetate (SPRM) has 2 uses: Emergency contraceptive and medica management of fibroids Tamoxifen: treatment of hormone receptor positive breast cancer; causes endometrial hyperplasia</li><li>\u2022 Dienogest is a progesterone; used in management of endometriosis (either alone or in combination with estrogen)</li><li>\u2022 Letrozole is commonly used for ovulation induction, but recent WHO guidelines have recommended its use in 1 st trimester MTP along with misoprostol</li><li>\u2022 Ulipristal acetate (SPRM) has 2 uses: Emergency contraceptive and medica management of fibroids</li><li>\u2022 Tamoxifen: treatment of hormone receptor positive breast cancer; causes endometrial hyperplasia</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Dienogest is a progesterone; used in management of endometriosis (either alone or in combination with estrogen) Letrozole is commonly used for ovulation induction, but recent WHO guidelines have recommended its use in 1 st trimester MTP along with misoprostol Ulipristal acetate (SPRM) has 2 uses: Emergency contraceptive and medica management of fibroids Tamoxifen: treatment of hormone receptor positive breast cancer; causes endometrial hyperplasia</li><li>\u27a4 Dienogest is a progesterone; used in management of endometriosis (either alone or in combination with estrogen)</li><li>\u27a4 Letrozole is commonly used for ovulation induction, but recent WHO guidelines have recommended its use in 1 st trimester MTP along with misoprostol</li><li>\u27a4 Ulipristal acetate (SPRM) has 2 uses: Emergency contraceptive and medica management of fibroids</li><li>\u27a4 Tamoxifen: treatment of hormone receptor positive breast cancer; causes endometrial hyperplasia</li><li>\u27a4 Ref: Williams Gynecology 3 rd edition</li><li>\u27a4 Ref: Williams Gynecology 3 rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e0733076",
      "audio": ""
    },
    {
      "text": "Which of the following is a correct indication for the use of gonadotropin-releasing hormone (GnRH) agonists in gynecology?",
      "options": [
        {
          "label": "A",
          "text": "Treatment of endometriosis",
          "correct": true
        },
        {
          "label": "B",
          "text": "Ovulation induction in infertility",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hormone replacement therapy in menopause",
          "correct": false
        },
        {
          "label": "D",
          "text": "Management of polycystic ovary syndrome (PCOS)",
          "correct": false
        }
      ],
      "correct_answer": "A. Treatment of endometriosis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Treatment of endometriosis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Gonadotropin-releasing hormone (GnRH) agonists are commonly used in gynecology for the treatment of endometriosis. GnRH agonists work by initially stimulating the release of gonadotropins, which leads to an initial increase in estrogen production. However, with continued use, they suppress the production of gonadotropins, leading to a decrease in estrogen levels and subsequent reduction in the growth and symptoms associated with endometriosis. Other uses of GnRh agonists include Central precocious puberty IVF cycles (long protocol and also as a trigger in women at high risk of developing OHSS) Endometriosis Fibroid uterus AUB Hirsutism Pre-menstrual syndrome</li><li>\u2022 Gonadotropin-releasing hormone (GnRH) agonists are commonly used in gynecology for the treatment of endometriosis. GnRH agonists work by initially stimulating the release of gonadotropins, which leads to an initial increase in estrogen production. However, with continued use, they suppress the production of gonadotropins, leading to a decrease in estrogen levels and subsequent reduction in the growth and symptoms associated with endometriosis. Other uses of GnRh agonists include Central precocious puberty IVF cycles (long protocol and also as a trigger in women at high risk of developing OHSS) Endometriosis Fibroid uterus AUB Hirsutism Pre-menstrual syndrome</li><li>\u2022 Central precocious puberty IVF cycles (long protocol and also as a trigger in women at high risk of developing OHSS) Endometriosis Fibroid uterus AUB Hirsutism Pre-menstrual syndrome</li><li>\u2022 Central precocious puberty</li><li>\u2022 IVF cycles (long protocol and also as a trigger in women at high risk of developing OHSS)</li><li>\u2022 Endometriosis</li><li>\u2022 Fibroid uterus</li><li>\u2022 AUB</li><li>\u2022 Hirsutism</li><li>\u2022 Pre-menstrual syndrome</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option B: Ovulation induction in infertility: Drug of choice is clomiphene citrate and letrozole</li><li>\u2022 Option B:</li><li>\u2022 Option C: Hormone replacement therapy in menopause: Drug of choice is estrogen + progesterone</li><li>\u2022 Option C:</li><li>\u2022 Option D: Management of polycystic ovary syndrome (PCOS): Treatment is Lifestyle measures + Depending on the patients concerns:</li><li>\u2022 Option D:</li><li>\u2022 Infertility: Letrozole Delayed cycles: Combined OCPs (with preferably a 4th generation progesterone like drosperinone) Hirsutism: Antiandrogrens or an OCP with the progesterone component being an anti-androgen (like cyproterone acetate)</li><li>\u2022 Infertility: Letrozole</li><li>\u2022 Delayed cycles: Combined OCPs (with preferably a 4th generation progesterone like drosperinone)</li><li>\u2022 Hirsutism: Antiandrogrens or an OCP with the progesterone component being an anti-androgen (like cyproterone acetate)</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Uses of GnRh agonists include Central precocious puberty IVF cycles (long protocol and also as a trigger in women at high risk of developing OHSS) Endometriosis Fibroid uterus AUB Hirsutism Pre-menstrual syndrome</li><li>\u27a4 Uses of GnRh agonists include Central precocious puberty IVF cycles (long protocol and also as a trigger in women at high risk of developing OHSS) Endometriosis Fibroid uterus AUB Hirsutism Pre-menstrual syndrome</li><li>\u27a4 Central precocious puberty IVF cycles (long protocol and also as a trigger in women at high risk of developing OHSS) Endometriosis Fibroid uterus AUB Hirsutism Pre-menstrual syndrome</li><li>\u27a4 Central precocious puberty</li><li>\u27a4 IVF cycles (long protocol and also as a trigger in women at high risk of developing OHSS)</li><li>\u27a4 Endometriosis</li><li>\u27a4 Fibroid uterus</li><li>\u27a4 AUB</li><li>\u27a4 Hirsutism</li><li>\u27a4 Pre-menstrual syndrome</li><li>\u27a4 Ref: Williams Gynecology 3 rd edition</li><li>\u27a4 Ref: Williams Gynecology 3 rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0d673c67",
      "audio": ""
    },
    {
      "text": "Which drug is found in the image shown?",
      "options": [
        {
          "label": "A",
          "text": "Norgestrel",
          "correct": false
        },
        {
          "label": "B",
          "text": "Etonorgestrel",
          "correct": false
        },
        {
          "label": "C",
          "text": "Levonorgestrel",
          "correct": true
        },
        {
          "label": "D",
          "text": "Dienogest",
          "correct": false
        }
      ],
      "correct_answer": "C. Levonorgestrel",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/16/10.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Levonorgestrel</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 The image is an intra-uterine device which contains Levonorgestrel (MIRENA) Mirena is a type of Levonorgestrel \u2013 Intrauterine System (LNG-IUS) It contains levonorgestrel \u2013 52 mg in total with a release rate of 20\u03bcg/ day Effective life: 5 years (In 2023, the manufacturer extended its use as a contraceptive to 8 years) Uses: Contraception Non contraceptive uses (Mnemonic : Mirena S a f ekeeps End angered A nimals) End ometriosis S ymptomatic fibroid (not distorting the cavity) End ometrial hyperplasia A denomyosis Contraindications to Mirena: Unexplained uterine or vaginal bleeding Post abortal sepsis Puerperal sepsis Endometrial cancer Cervical cancer Gestational trophoblastic neoplasia Current Pelvic inflammatory disease Genital Tuberculosis Large fibroid distorting the uterine cavity Mullerian anomalies distorting the uterine cavity</li><li>\u2022 The image is an intra-uterine device which contains Levonorgestrel (MIRENA)</li><li>\u2022 Mirena is a type of Levonorgestrel \u2013 Intrauterine System (LNG-IUS)</li><li>\u2022 It contains levonorgestrel \u2013 52 mg in total with a release rate of 20\u03bcg/ day</li><li>\u2022 Effective life: 5 years (In 2023, the manufacturer extended its use as a contraceptive to 8 years)</li><li>\u2022 Uses: Contraception Non contraceptive uses (Mnemonic : Mirena S a f ekeeps End angered A nimals) End ometriosis S ymptomatic fibroid (not distorting the cavity) End ometrial hyperplasia A denomyosis</li><li>\u2022 Uses:</li><li>\u2022 Contraception Non contraceptive uses (Mnemonic : Mirena S a f ekeeps End angered A nimals) End ometriosis S ymptomatic fibroid (not distorting the cavity) End ometrial hyperplasia A denomyosis</li><li>\u2022 Contraception</li><li>\u2022 Non contraceptive uses (Mnemonic : Mirena S a f ekeeps End angered A nimals) End ometriosis S ymptomatic fibroid (not distorting the cavity) End ometrial hyperplasia A denomyosis</li><li>\u2022 Mirena</li><li>\u2022 S</li><li>\u2022 f</li><li>\u2022 End</li><li>\u2022 A</li><li>\u2022 End ometriosis S ymptomatic fibroid (not distorting the cavity) End ometrial hyperplasia A denomyosis</li><li>\u2022 End ometriosis</li><li>\u2022 End</li><li>\u2022 S ymptomatic fibroid (not distorting the cavity)</li><li>\u2022 S</li><li>\u2022 End ometrial hyperplasia</li><li>\u2022 End</li><li>\u2022 A denomyosis</li><li>\u2022 A</li><li>\u2022 Contraindications to Mirena: Unexplained uterine or vaginal bleeding Post abortal sepsis Puerperal sepsis Endometrial cancer Cervical cancer Gestational trophoblastic neoplasia Current Pelvic inflammatory disease Genital Tuberculosis Large fibroid distorting the uterine cavity Mullerian anomalies distorting the uterine cavity</li><li>\u2022 Contraindications to Mirena:</li><li>\u2022 Unexplained uterine or vaginal bleeding Post abortal sepsis Puerperal sepsis Endometrial cancer Cervical cancer Gestational trophoblastic neoplasia Current Pelvic inflammatory disease Genital Tuberculosis Large fibroid distorting the uterine cavity Mullerian anomalies distorting the uterine cavity</li><li>\u2022 Unexplained uterine or vaginal bleeding</li><li>\u2022 Post abortal sepsis</li><li>\u2022 Puerperal sepsis</li><li>\u2022 Endometrial cancer</li><li>\u2022 Cervical cancer</li><li>\u2022 Gestational trophoblastic neoplasia</li><li>\u2022 Current Pelvic inflammatory disease</li><li>\u2022 Genital Tuberculosis</li><li>\u2022 Large fibroid distorting the uterine cavity</li><li>\u2022 Mullerian anomalies distorting the uterine cavity</li><li>\u2022 **Also remember LNG is the progesterone component in</li><li>\u2022 **Also remember LNG is the progesterone component in</li><li>\u2022 Combined oral contraceptive pill 3rd generation Intra uterine devices Emergency contraceptive Contraceptive implant (Norplant and Jadelle)</li><li>\u2022 Combined oral contraceptive pill</li><li>\u2022 Combined oral contraceptive pill</li><li>\u2022 3rd generation Intra uterine devices</li><li>\u2022 3rd generation Intra uterine devices</li><li>\u2022 Emergency contraceptive</li><li>\u2022 Emergency contraceptive</li><li>\u2022 Contraceptive implant (Norplant and Jadelle)</li><li>\u2022 Contraceptive implant (Norplant and Jadelle)</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option A: Norgeterel: This is the progesterone component of some combined oral contracpetive pills</li><li>\u2022 Option A:</li><li>\u2022 Option B: Etonorgesterel: This is the progesterone component of the vaginal ring and also of implanon</li><li>\u2022 Option B:</li><li>\u2022 Option D: Dienogest: This is the progesterone component of some progesterone only pills and also in combined oral contraceptive pills</li><li>\u2022 Option D:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Mirena is a type of Levonorgestrel \u2013 Intrauterine System (LNG-IUS) It contains levonorgestrel \u2013 52 mg in total with a release rate of 20\u03bcg/ day Effective life: 5 years (In 2023, the manufacturer extended its use as a contraceptive to 8 years) Uses: Contraception Non contraceptive uses (Mnemonic : Mirena S a f ekeeps End angered A nimals) End ometriosis S ymptomatic fibroid (not distorting the cavity) End ometrial hyperplasia A denomyosis</li><li>\u27a4 Mirena is a type of Levonorgestrel \u2013 Intrauterine System (LNG-IUS)</li><li>\u27a4 It contains levonorgestrel \u2013 52 mg in total with a release rate of 20\u03bcg/ day</li><li>\u27a4 Effective life: 5 years (In 2023, the manufacturer extended its use as a contraceptive to 8 years)</li><li>\u27a4 Uses: Contraception Non contraceptive uses (Mnemonic : Mirena S a f ekeeps End angered A nimals) End ometriosis S ymptomatic fibroid (not distorting the cavity) End ometrial hyperplasia A denomyosis</li><li>\u27a4 Uses:</li><li>\u27a4 Contraception Non contraceptive uses (Mnemonic : Mirena S a f ekeeps End angered A nimals) End ometriosis S ymptomatic fibroid (not distorting the cavity) End ometrial hyperplasia A denomyosis</li><li>\u27a4 Contraception</li><li>\u27a4 Non contraceptive uses (Mnemonic : Mirena S a f ekeeps End angered A nimals) End ometriosis S ymptomatic fibroid (not distorting the cavity) End ometrial hyperplasia A denomyosis</li><li>\u27a4 Mirena</li><li>\u27a4 S</li><li>\u27a4 f</li><li>\u27a4 End</li><li>\u27a4 A</li><li>\u27a4 End ometriosis S ymptomatic fibroid (not distorting the cavity) End ometrial hyperplasia A denomyosis</li><li>\u27a4 End ometriosis</li><li>\u27a4 End</li><li>\u27a4 S ymptomatic fibroid (not distorting the cavity)</li><li>\u27a4 S</li><li>\u27a4 End ometrial hyperplasia</li><li>\u27a4 End</li><li>\u27a4 A denomyosis</li><li>\u27a4 A</li><li>\u27a4 Ref: Page no 272, Shaw\u2019s Textbook of Gynecology, 16 th edition</li><li>\u27a4 Ref: Page no 272, Shaw\u2019s Textbook of Gynecology, 16 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "95f68ad1",
      "audio": ""
    },
    {
      "text": "Which of the following statements regarding ormeloxifene is correct?",
      "options": [
        {
          "label": "A",
          "text": "Ormeloxifene is a selective progesterone receptor modulator (SPRM)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Ormeloxifene is primarily used as an emergency contraceptive",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ormeloxifene is approved for long-term contraception and the treatment of heavy menstrual bleeding",
          "correct": true
        },
        {
          "label": "D",
          "text": "Ormeloxifene is contraindicated in women with a history of breast cancer.",
          "correct": false
        }
      ],
      "correct_answer": "C. Ormeloxifene is approved for long-term contraception and the treatment of heavy menstrual bleeding",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Ormeloxifene is approved for long-term contraception and the treatment of heavy menstrual bleeding.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Ormeloxifene is commonly known as CENTCHROMAN/ CHHAYA</li><li>\u2022 It is a selective estrogen receptor modulator (SERM) Developed by the Central Drug Research Institute, Lucknow It is a non \u2013 hormonal, synthetic contraceptive Low cost Initially marketed as Saheli and now as Chhaya by the Govt of India Contains 30 mg Recommended dose for contraception: 1 tablet twice weekly from the 1 st day of menstruation for 3 months followed by once a week It has recently been used as a drug for heavy menstrual bleeding 99% effective Contra-indications to Ormeloxifene PCOS (Absolutely c/i) Liver disease (Absolutely c/i) DVT (Relatively c/i) SLE  (Relatively c/i) Migraine with aura (Relatively c/i)</li><li>\u2022 It is a selective estrogen receptor modulator (SERM)</li><li>\u2022 Developed by the Central Drug Research Institute, Lucknow</li><li>\u2022 It is a non \u2013 hormonal, synthetic contraceptive</li><li>\u2022 Low cost</li><li>\u2022 Initially marketed as Saheli and now as Chhaya by the Govt of India</li><li>\u2022 Contains 30 mg</li><li>\u2022 Recommended dose for contraception: 1 tablet twice weekly from the 1 st day of menstruation for 3 months followed by once a week</li><li>\u2022 It has recently been used as a drug for heavy menstrual bleeding</li><li>\u2022 99% effective</li><li>\u2022 Contra-indications to Ormeloxifene PCOS (Absolutely c/i) Liver disease (Absolutely c/i) DVT (Relatively c/i) SLE  (Relatively c/i) Migraine with aura (Relatively c/i)</li><li>\u2022 Contra-indications to Ormeloxifene</li><li>\u2022 PCOS (Absolutely c/i) Liver disease (Absolutely c/i) DVT (Relatively c/i) SLE  (Relatively c/i) Migraine with aura (Relatively c/i)</li><li>\u2022 PCOS (Absolutely c/i)</li><li>\u2022 Liver disease (Absolutely c/i)</li><li>\u2022 DVT (Relatively c/i)</li><li>\u2022 SLE  (Relatively c/i)</li><li>\u2022 Migraine with aura (Relatively c/i)</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option A: Ormeloxifene is a selective progesterone receptor modulator (SPRM): It is an SERM</li><li>\u2022 Option A:</li><li>\u2022 Option B: Ormeloxifene is primarily used as an emergency contraceptive: It is not used as an emergency contraceptive. LNG, Combined OCPs and Uliprostal are used as emergency contracpetives</li><li>\u2022 Option B:</li><li>\u2022 Option C: Ormeloxifene is contraindicated in women with a history of breast cancer: Ormeloxifene is not contra-indicated in breast cancer; it is MEC 2 (benefits outweigh the risks) and can be safely given</li><li>\u2022 Option C:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ormeloxifene is commonly known as CENTCHROMAN/ CHHAYA</li><li>\u27a4 It is a selective estrogen receptor modulator (SERM) Developed by the Central Drug Research Institute, Lucknow It is a non \u2013 hormonal, synthetic contraceptive Low cost Initially marketed as Saheli and now as Chhaya by the Govt of India Contains 30 mg Recommended dose for contraception: 1 tablet twice weekly from the 1 st day of menstruation for 3 months followed by once a week It has recently been used as a drug for heavy menstrual bleeding 99% effective Contra-indications to Ormeloxifene PCOS (Absolutely c/i) Liver disease (Absolutely c/i) DVT (Relatively c/i) SLE  (Relatively c/i) Migraine with aura (Relatively c/i)</li><li>\u27a4 It is a selective estrogen receptor modulator (SERM)</li><li>\u27a4 Developed by the Central Drug Research Institute, Lucknow</li><li>\u27a4 It is a non \u2013 hormonal, synthetic contraceptive</li><li>\u27a4 Low cost</li><li>\u27a4 Initially marketed as Saheli and now as Chhaya by the Govt of India</li><li>\u27a4 Contains 30 mg</li><li>\u27a4 Recommended dose for contraception: 1 tablet twice weekly from the 1 st day of menstruation for 3 months followed by once a week</li><li>\u27a4 It has recently been used as a drug for heavy menstrual bleeding</li><li>\u27a4 99% effective</li><li>\u27a4 Contra-indications to Ormeloxifene PCOS (Absolutely c/i) Liver disease (Absolutely c/i) DVT (Relatively c/i) SLE  (Relatively c/i) Migraine with aura (Relatively c/i)</li><li>\u27a4 Contra-indications to Ormeloxifene</li><li>\u27a4 PCOS (Absolutely c/i) Liver disease (Absolutely c/i) DVT (Relatively c/i) SLE  (Relatively c/i) Migraine with aura (Relatively c/i)</li><li>\u27a4 PCOS (Absolutely c/i)</li><li>\u27a4 Liver disease (Absolutely c/i)</li><li>\u27a4 DVT (Relatively c/i)</li><li>\u27a4 SLE  (Relatively c/i)</li><li>\u27a4 Migraine with aura (Relatively c/i)</li><li>\u27a4 Ref: Page no 278, Shaw\u2019s Textbook of Gynecology, 7 th edition</li><li>\u27a4 Ref: Page no 278, Shaw\u2019s Textbook of Gynecology, 7 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "546f8a63",
      "audio": ""
    },
    {
      "text": "Match the name of the contraceptive (as made available by the Govt of India) with the drug it contains:",
      "options": [
        {
          "label": "A",
          "text": "1a 2c 3b 4d",
          "correct": false
        },
        {
          "label": "B",
          "text": "1c 2b 3a 4d",
          "correct": true
        },
        {
          "label": "C",
          "text": "1c 2d 3a 4b",
          "correct": false
        },
        {
          "label": "D",
          "text": "1d 2c 3a 4b",
          "correct": false
        }
      ],
      "correct_answer": "B. 1c 2b 3a 4d",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/05/2.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/05/screenshot-2023-09-05-171235.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/05/screenshot-2023-09-05-171235.jpg"
      ],
      "explanation": "<p><strong>Ans. B. 1c 2b 3a 4d</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The hormonal contraceptives made available by the Govt of India are as follows</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref: https://main.mohfw.gov.in/sites/default/files/06%20Chapter%2093AN2018-19.pdf</li><li>\u27a4 Ref:</li><li>\u27a4 https://main.mohfw.gov.in/sites/default/files/06%20Chapter%2093AN2018-19.pdf</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3713d060",
      "audio": ""
    },
    {
      "text": "In the management of endometriosis, which of the following is the primary mechanism of action of danazol?",
      "options": [
        {
          "label": "A",
          "text": "Inhibition of estrogen production",
          "correct": true
        },
        {
          "label": "B",
          "text": "Stimulation of progesterone receptor activity",
          "correct": false
        },
        {
          "label": "C",
          "text": "Suppression of LH secretion",
          "correct": false
        },
        {
          "label": "D",
          "text": "Enhancement of FSH release",
          "correct": false
        }
      ],
      "correct_answer": "A. Inhibition of estrogen production",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/19/screenshot-2023-12-19-115229.jpg"
      ],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Danazol is an isoxazole derivative of 17-alpha ethinyl testosterone. It is strictly anti-gonadotropin but acts as an androgen agonist. Mode of action: The mechanism of action is complex and includes the following: Acting on the hypothalamo-pituitary gonadal axis \u2192 depression of frequency of GnRH pulses \u2192 suppression of pituitary FSH and LH surge. There is, however, no change in the basal gonadotropin level while the estrogen levels are reduced. Reduces the liver synthesis of SHBG and as such, free testosterone is increased which in turn causes endometrial atrophy. Acts directly on the ovaries, inhibiting the enzymes responsible for steroidogenesis \u2013 reducing the estrogen level Binds with steroid receptors on the endometrium and also in the ectopic endometrial sites Immunologic effects of danazol include decrease in serum immunoglobulins, interleukin-1 and TNF production. This effect helps in the regression of endometriosis. The net result is production of an hypoestrogenic state Indications of use of Danazol: (Although it is now not very commonly used)</li><li>\u2022 Danazol is an isoxazole derivative of 17-alpha ethinyl testosterone.</li><li>\u2022 It is strictly anti-gonadotropin but acts as an androgen agonist.</li><li>\u2022 Mode of action: The mechanism of action is complex and includes the following: Acting on the hypothalamo-pituitary gonadal axis \u2192 depression of frequency of GnRH pulses \u2192 suppression of pituitary FSH and LH surge. There is, however, no change in the basal gonadotropin level while the estrogen levels are reduced. Reduces the liver synthesis of SHBG and as such, free testosterone is increased which in turn causes endometrial atrophy. Acts directly on the ovaries, inhibiting the enzymes responsible for steroidogenesis \u2013 reducing the estrogen level Binds with steroid receptors on the endometrium and also in the ectopic endometrial sites Immunologic effects of danazol include decrease in serum immunoglobulins, interleukin-1 and TNF production. This effect helps in the regression of endometriosis.</li><li>\u2022 Acting on the hypothalamo-pituitary gonadal axis \u2192 depression of frequency of GnRH pulses \u2192 suppression of pituitary FSH and LH surge. There is, however, no change in the basal gonadotropin level while the estrogen levels are reduced. Reduces the liver synthesis of SHBG and as such, free testosterone is increased which in turn causes endometrial atrophy. Acts directly on the ovaries, inhibiting the enzymes responsible for steroidogenesis \u2013 reducing the estrogen level Binds with steroid receptors on the endometrium and also in the ectopic endometrial sites Immunologic effects of danazol include decrease in serum immunoglobulins, interleukin-1 and TNF production. This effect helps in the regression of endometriosis.</li><li>\u2022 Acting on the hypothalamo-pituitary gonadal axis \u2192 depression of frequency of GnRH pulses \u2192 suppression of pituitary FSH and LH surge. There is, however, no change in the basal gonadotropin level while the estrogen levels are reduced.</li><li>\u2022 Reduces the liver synthesis of SHBG and as such, free testosterone is increased which in turn causes endometrial atrophy.</li><li>\u2022 Acts directly on the ovaries, inhibiting the enzymes responsible for steroidogenesis \u2013 reducing the estrogen level</li><li>\u2022 Binds with steroid receptors on the endometrium and also in the ectopic endometrial sites</li><li>\u2022 Immunologic effects of danazol include decrease in serum immunoglobulins, interleukin-1 and TNF production. This effect helps in the regression of endometriosis.</li><li>\u2022 The net result is production of an hypoestrogenic state</li><li>\u2022 The net result is production of an hypoestrogenic state</li><li>\u2022 Indications of use of Danazol: (Although it is now not very commonly used)</li><li>\u2022 Indications of use of Danazol: (Although it is now not very commonly used)</li><li>\u2022 Endometriosis Precocious puberty AUB PMS Symptomatic fibroid Benign fibrocystic disease of the breasts (mastalgia) Prior to hysteroscopic endometrial ablation, to make the endometrium thin</li><li>\u2022 Endometriosis</li><li>\u2022 Precocious puberty</li><li>\u2022 AUB</li><li>\u2022 PMS</li><li>\u2022 Symptomatic fibroid</li><li>\u2022 Benign fibrocystic disease of the breasts (mastalgia)</li><li>\u2022 Prior to hysteroscopic endometrial ablation, to make the endometrium thin</li><li>\u2022 Side effects of Danazol</li><li>\u2022 Side effects of Danazol</li><li>\u2022 Side effects of Danazol</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Indications of use of Danazol: (Although it is now not very commonly used)</li><li>\u27a4 Indications of use of Danazol: (Although it is now not very commonly used)</li><li>\u27a4 Indications of use of Danazol: (Although it is now not very commonly used)</li><li>\u27a4 8. Endometriosis</li><li>\u27a4 9. Precocious puberty</li><li>\u27a4 10. AUB</li><li>\u27a4 11. PMS</li><li>\u27a4 12. Symptomatic fibroid</li><li>\u27a4 13. Benign fibrocystic disease of the breasts (mastalgia)</li><li>\u27a4 14. Prior to hysteroscopic endometrial ablation, to make the endometrium thin</li><li>\u27a4 Ref: Page no 530, DC Dutta\u2019s Textbook of Gynecology 6 th edition</li><li>\u27a4 Ref: Page no 530, DC Dutta\u2019s Textbook of Gynecology 6 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "de1f5fe3",
      "audio": ""
    },
    {
      "text": "Which of the following medications can be added to improve the clomiphene response in women with PCOS?",
      "options": [
        {
          "label": "A",
          "text": "Dehydroepiandrosterone (DHEA)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Insulin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Metformin",
          "correct": true
        },
        {
          "label": "D",
          "text": "Progesterone",
          "correct": false
        }
      ],
      "correct_answer": "C. Metformin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Metformin</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Many women with PCOS also have insulin resistance Insulin resistance leads to compensatory hyperinsulinemia and dyslipidemia. Interventions that reduce circulating insulin levels in women with PCOS may restore normal reproductive endocrine function. Insulin-sensitizing agents like Metformin help in the treatment of PCOS. Metformin administered to women with PCOS, increased the frequency of spontaneous ovulation, menstrual cyclicity, and ovulatory response to Clomiphene citrate</li><li>\u2022 Many women with PCOS also have insulin resistance</li><li>\u2022 Insulin resistance leads to compensatory hyperinsulinemia and dyslipidemia.</li><li>\u2022 Interventions that reduce circulating insulin levels in women with PCOS may restore normal reproductive endocrine function.</li><li>\u2022 Insulin-sensitizing agents like Metformin help in the treatment of PCOS.</li><li>\u2022 Metformin administered to women with PCOS, increased the frequency of spontaneous ovulation, menstrual cyclicity, and ovulatory response to Clomiphene citrate</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Metformin administered to women with PCOS, increased the frequency of spontaneous ovulation, menstrual cyclicity, and ovulatory response to Clomiphene citrate</li><li>\u27a4 Metformin administered to women with PCOS, increased the frequency of spontaneous ovulation, menstrual cyclicity, and ovulatory response to Clomiphene citrate</li><li>\u27a4 Ref: Page 452, Williams Gynecology 3 rd edition</li><li>\u27a4 Ref: Page 452, Williams Gynecology 3 rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fb951d3f",
      "audio": ""
    }
  ]
}